Pyridine Nucleotide Synthesis in Host Tissues of Tumour-Bearing Animals
1957

Pyridine Nucleotide Synthesis in Tumor-Bearing Animals

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): M. V. NARIURKAR, U. S. KUMTA, M. B. SAHASRABUDHE

Primary Institution: Atomic Energy Establishment, Indian Cancer Research Centre

Hypothesis

The presence of tumors affects the levels of pyridine nucleotides in host tissues.

Conclusion

Tumor presence significantly lowers pyridine nucleotide levels in the host tissues.

Supporting Evidence

  • The levels of pyridine nucleotides were significantly lower in the livers and spleens of tumor-bearing animals compared to controls.
  • Fibrosarcoma-bearing Swiss mice showed a decrease of 16.4% and 26.1% in liver and spleen pyridine nucleotide levels, respectively.
  • Yoshida sarcoma-bearing rats exhibited a decrease of 43.1% and 18.0% in liver and spleen pyridine nucleotide levels, respectively.
  • Administration of nicotinamide increased pyridine nucleotide synthesis in normal tissues but not in tumor-bearing tissues.

Takeaway

When animals have tumors, they have less of a substance called pyridine nucleotides, which is important for their health.

Methodology

The study involved transplanting two types of tumors into rats and mice and measuring pyridine nucleotide levels in their livers and spleens.

Limitations

The study does not clarify the exact mechanism by which tumors affect pyridine nucleotide synthesis.

Participant Demographics

Wistar rats and Swiss mice, aged 6-8 weeks.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication